PMID- 21348543 OWN - NLM STAT- MEDLINE DCOM- 20110620 LR - 20160707 IS - 1179-1888 (Electronic) IS - 1175-0561 (Linking) VI - 12 IP - 2 DP - 2011 Apr 1 TI - Response to narrow-band UVB--vitiligo-melasma versus vitiligo: a comparative study. PG - 127-32 LID - 10.2165/11537120-000000000-00000 [doi] AB - BACKGROUND: Vitiligo is the most common depigmentary disorder of the skin and hair, resulting from selective destruction of melanocytes. Melasma, a hyperpigmentary disorder, presents as irregular, brown, macular hypermelanosis. A small subset of vitiligo patients paradoxically also have melasma. OBJECTIVE: To evaluate and compare the response to narrow-band UVB in a group of patients with vitiligo, and another group of patients with vitiligo and coexisting melasma (vitiligo-melasma). METHODS: Patients in both groups were treated with narrow-band UVB and a comparison of the zonal repigmentation was made at 4, 8, and 12 weeks after the initiation of therapy. RESULTS: At the end of 12 weeks, 86% of patients in the vitiligo-melasma group attained >/=75% pigmentation on the face, whereas this was achieved in only 12.5% of patients in the vitiligo group. Over the limbs, 73% of patients in the vitiligo-melasma group attained 75% or more pigmentation at the end of 12 weeks compared with only 9% in the vitiligo group. On the trunk, only 20% of vitiligo-melasma patients showed >/=75% pigmentation at 12 weeks compared with 63% of patients in the vitiligo group. CONCLUSION: Patients having both vitiligo and melasma have a significantly better prognosis for repigmentation on the face and limbs with narrow-band UVB compared with patients with vitiligo alone; the vitiligo-melasma patients achieve repigmentation much earlier and also attain a greater level of repigmentation. Unexpectedly, for truncal lesions, patients with vitiligo alone responded better than those with both conditions. Although the vitiligo-melasma group with truncal lesions started repigmenting earlier, the final pigmentation was more extensive in the vitiligo group. FAU - Sharma, Parikshit AU - Sharma P AD - Department of Dermatology, Kasturba Medical College, Mangalore, India. drparikshit_sharma@yahoo.com FAU - Pai, Harsha S AU - Pai HS FAU - Pai, Ganesh S AU - Pai GS FAU - Kuruvila, Maria AU - Kuruvila M FAU - Kolar, Reshma AU - Kolar R LA - eng PT - Controlled Clinical Trial PT - Journal Article PL - New Zealand TA - Am J Clin Dermatol JT - American journal of clinical dermatology JID - 100895290 SB - IM MH - Adolescent MH - Adult MH - Child MH - Extremities MH - Face MH - Female MH - Follow-Up Studies MH - Humans MH - Male MH - Melanosis/complications/pathology/*radiotherapy MH - Middle Aged MH - Prognosis MH - Skin Pigmentation MH - Treatment Outcome MH - Ultraviolet Therapy/*methods MH - Vitiligo/complications/pathology/*radiotherapy MH - Young Adult EDAT- 2011/02/26 06:00 MHDA- 2011/06/21 06:00 CRDT- 2011/02/26 06:00 PHST- 2011/02/26 06:00 [entrez] PHST- 2011/02/26 06:00 [pubmed] PHST- 2011/06/21 06:00 [medline] AID - 4 [pii] AID - 10.2165/11537120-000000000-00000 [doi] PST - ppublish SO - Am J Clin Dermatol. 2011 Apr 1;12(2):127-32. doi: 10.2165/11537120-000000000-00000.